| DONEPEZIL HYDROCHLORIDE | Corium | ||
| 5MG, 10MG ; Transdermal System |
Less Than $1000 mn
|
||
| None | None | ||
|
Less Than 5
|
None | ||
| None | None | ||
| ADLARITY is an acetylcholinesterase inhibitor indicated for the treatment of mild, moderate, and severe dementia of the Alzheimer’s type. | |||
|
Yes
| |||
| ADLARITY | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 | Patent 10 | Patent 11 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| *** ********* | |||||||||||
| ******* *** ******* *** **** **** *********** ************** | ******* ********** * ********* ******* *** ******* *** **** **** *********** ************** | ******* ********** * ********* ******* *** ******* *** **** **** *********** ************** | *********** ******** ******* **** **************** ************* ** **** ******** | ********* *********** ******** ****** | ********* *********** ******** ****** | ******* *** ******** *********'* ******* **** ********* *********** ****** | ********* *********** ******** ****** | ******* *** ******* *** **** **** *********** ************** | ******* *** ******* *** **** **** *********** ************** | ******* ********** * ********* ******* *** ******* *** **** **** *********** ************** |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|